2005 Sep 1;58(5):424-8. doi: 10.1016/j.biopsych.2005.04.043. This meta-analysis was performed to determine the efficacy and safety of riluzole used for DD. In a secondary analysis of survival at separate time points, there was a significant survival advantage with riluzole 100 mg/day at 6, 9, 12, and 15 months, but not at 3 or 18 months.84. The Cochrane review concluded that riluzole 100 mg daily is “reasonably safe and probably prolongs median survival by ~2–3 months” in patients with ALS. 2016 Apr;75:24-30. doi: 10.1016/j.jpsychires.2016.01.003. 2019 Sep 26;16(19):3596. doi: 10.3390/ijerph16193596. Other side effects include: vomiting. We suggest carrying out further work to provide definitive evidence for the benefit of riluzole in psychiatric illness. Our Rilutek (riluzole) Side Effects Drug Center provides a comprehensive view of available drug information on the potential side effects when taking this medication. Prevention and treatment information (HHS). The longer relapse time of riluzole group might have clinical significance to some extent, although this had no statistical difference. Furthermore, riluzole showed favorable safety for DD. Riluzole produced a 36 +/- 17% depression of fiver volley amplitudes, which, based on input/output analysis, could completely account for the depression of EPSPs. 2014 Oct 31;18(1):pyu039. The Associations between Mental Well-Being and Adherence to Physical Activity Guidelines in Patients with Cardiovascular Disease: Results from the Scottish Health Survey. Epub 2016 Jan 7. Prevention and treatment information (HHS). National Library of Medicine 2015 Sep 23;(9):CD011612. doi: 10.1002/14651858.CD011612.pub2. Prog Neuropsychopharmacol Biol Psychiatry. Jan. 16, 2004 — Riluzole is associated with antidepressant effects in patients with treatment-resistant depression, according to results of an … Seven studies were also used for quantitative analysis, which revealed positive but non-significant effects on OCD and depression. Would you like email updates of new search results? A systematic search was performed using PubMed (Medline), Embase, Cochrane Database of Systematic Reviews and PsycINFO. Avoid driving or doing other tasks that require concentration until you know how Rilutek (riluzole) affects you. Response rates were higher in subjects receiving a dose of 150 mg/day (response rates at 100 mg/day were one-third [33%]; at 150 mg/day, one-half [50%]; and at 200 mg/day, one-eighth [13%]), although these differences were not statistically different. Keywords: Riluzole, an inhibitor of glutamate release, is approved by the FDA for the treatment of amyotrophic lateral sclerosis. Riluzole may harm an unborn baby. The primary outcome was change in depression severity and meta-analysis was performed using comprehensive meta-analysis software. 2015 Sep 29;(9):CD011611. Glutamatergic and GABAergic reactivity and cognition in 22q11.2 deletion syndrome and healthy volunteers: A randomized double-blind 7-Tesla pharmacological MRS study. FOIA The pharmacokinetic parameters of riluzole after multiple dose administration (4.5 days of treatment at 50 mg riluzole b.i.d.) 2020 Oct 27;81(6):20m13233. This site needs JavaScript to work properly. McCloud TL, Caddy C, Jochim J, Rendell JM, Diamond PR, Shuttleworth C, Brett D, Amit BH, McShane R, Hamadi L, Hawton K, Cipriani A. Cochrane Database Syst Rev. A point of entry may be the glutamatergic system since glutamatergic dysregulation contributes to multiple psychiatric disorders. Salardini E, Zeinoddini A, Mohammadinejad P, Khodaie-Ardakani MR, Zahraei N, Zeinoddini A, Akhondzadeh S. J Psychiatr Res. Ketamine's antidepressant efficacy is extended for at least four weeks in subjects with a family history of an alcohol use disorder. It may not be safe to breastfeed while using riluzole. eCollection 2020. received an overall rating of 2 out of 10 stars from 1 reviews. Subsequently, riluzole was studied in 14 patients with bipolar depression of moderate severity who had failed to respond to a prospective trial of lithium within therapeutic levels. Side effects requiring immediate medical attention The glutamate blocker riluzole may have longer-term beneficial effects as adjunctive treatment for some patients with treatment-resistant depression, according … These side effects are more likely to happen if you're taking other medicines that can also make you feel sleepy, or if you're taking recreational drugs or drinking too much alcohol. IS-BRC-1215-20018/DH_/Department of Health/United Kingdom. We showed that riluzole prolongs survival in the last clinical stage of ALS; this finding needs to be confirmed in a prospective study, and treatment effects at stage 1 still need to be analysed. Bethesda, MD 20894, Copyright Augmentation of selective serotonin or serotonin-noradrenaline reuptake inhibitors with riluzole may improve PTSD hyperarousal symptoms, according to study results published in … Twenty-three RCTs were included for qualitative analysis and showed positive effects of adjunctive/monotherapy riluzole in patients with OCD, depression, autism, substance abuse and schizophrenia. Vingerhoets C, Tse DH, van Oudenaren M, Hernaus D, van Duin E, Zinkstok J, Ramaekers JG, Jansen JF, McAlonan G, van Amelsvoort T. J Psychopharmacol. Front Pharmacol. Epub 2020 Jan 7. 2019 Aug;278:294-302. doi: 10.1016/j.psychres.2019.06.020. Kätzel D, Wolff AR, Bygrave AM, Bannerman DM. Call your doctor for medical advice about side effects. Biol Psychiatry. Commonly reported side effects of riluzole include: asthenia, nausea, and increased serum alanine aminotransferase. Caddy C, Amit BH, McCloud TL, Rendell JM, Furukawa TA, McShane R, Hawton K, Cipriani A. Cochrane Database Syst Rev. Riluzole was overall well tolerated and associated with positive effects in multiple psychiatric disorders in qualitative analysis, according to results from a … Clipboard, Search History, and several other advanced features are temporarily unavailable. Clipboard, Search History, and several other advanced features are temporarily unavailable. Should we expand the toolbox of psychiatric treatment methods to include Repetitive Transcranial Magnetic Stimulation (rTMS)? Augmentation of lithium with riluzole (mean daily dose 171 mg) for eight weeks resulted in significantly improved depressive symptoms [ 41 ]. 8600 Rockville Pike Applies to riluzole: oral suspension, oral tablet. are not affected in the elderly (≥ 70 years). Within 1 week, her Hamilton depression scale and Beck Depression Inventory scores decreased by 16 and 10 points, respectively. J Child Adolesc Psychopharmacol. Prog Neuropsychopharmacol Biol Psychiatry. A Cochrane Library review states a 9% gain in the probability of surviving 1 year. Copyright © 2020 Elsevier B.V. All rights reserved. [3]. Riluzole also did not delay relapse in ketamine responders, which is consistent with a prior report of lack of efficacy in 14 ketamine … FOIA This study examines if Riluzole, FDA approved for ALS, will improve symptoms of depression in Bipolar Disorder. Epub 2010 Mar 9. A meta-analysis of the efficacy of rTMS in psychiatric disorders. Rilutek (riluzole) can make you feel sleepy and dizzy. Find everything you need to know about Riluzole (Rilutek), including what it is used for, warnings, reviews, side effects, and interactions. 2010 Jul;71(7):873-84. doi: 10.4088/JCP.08m04872gre. 2010 Aug;20(4):309-15. doi: 10.1089/cap.2010.0009. Patients, ages 18 to 60 with a diagnosis of major depression without psychotic features, will in this pilot study (single arm, single-blind) receive riluzole (50-200 mg/day) for a period of 6 weeks. 2020 Oct 16;11:486811. doi: 10.3389/fphar.2020.486811. Hippocampal Hyperactivity as a Druggable Circuit-Level Origin of Aberrant Salience in Schizophrenia. Gender: No gender effect on riluzole pharmacokinetics has been found in young or elderly healthy subjects. Epub 2019 Jun 21. Please enable it to take advantage of the complete set of features! Am J Psychiatry, 2004, 161:171-174. Learn more about Riluzole (Rilutek) at EverydayHealth.com. In this meta-analysis riluzole showed no antidepressant efficacy compared to placebo in monotherapy or riluzole-ketamine combined therapy, while it might relieve depression severity to some extent in riluzole-citalopram therapy. There was some difference in depression severity change in riluzole-citalopram therapy. Accessibility National Library of Medicine Spangler PT, West JC, Dempsey CL, Possemato K, Bartolanzo D, Aliaga P, Zarate C, Vythilingam M, Benedek DM. Riluzole is not approved for use by anyone younger than 18 years old. Meta-analyses were performed using Comprehensive Meta-Analysis software. Epub 2020 May 25. J Clin Psychiatry. We evaluated the evidence from randomized controlled trials (RCTs) regarding the use of the glutamatergic drug riluzole in mental illnesses; and conducted preliminary meta-analyses of its effectiveness in treating obsessive-compulsive disorder (OCD) and depression. 2020 Nov 19;11:548505. doi: 10.3389/fpsyt.2020.548505. After we obtained written informed consent, riluzole, 50 mg b.i.d., was added to her current medication regimen. Salman A, Sellami M, Al-Mohannadi AS, Chun S. Int J Environ Res Public Health. The studies included in this systematic review were highly heterogeneous and the number of studies was limited per diagnostic condition. Riluzole combination therapy for moderate-to-severe major depressive disorder: A randomized, double-blind, placebo-controlled trial. Niciu MJ, Luckenbaugh DA, Ionescu DF, Richards EM, Vande Voort JL, Ballard ED, Brutsche NE, Furey ML, Zarate CA Jr. Int J Neuropsychopharmacol. You may report side effects to FDA at 1-800-FDA-1088. Others, such as amibegron and sipatrigine, have been shown to be efficacious only in animal models of depression and their benefit is therefore highly speculative. Riluzole is available in tablet and liquid form. Riluzole's effects on potassium channels have also been measured, but possibly not at clinically meaningful riluzole concentrations (Ahn et al. Riluzole augmentation in treatment-resistant obsessive-compulsive disorder: an open-label trial. 2020 Aug;34(8):856-863. doi: 10.1177/0269881120922977. 2008. Bethesda, MD 20894, Copyright Approved in 1995 by the FDA, it was originally developed by the French company Rhone-Poulenc Rorer and is now marketed by Sanofi. The ALS stage at which benefit occurs is important for counselling of patients before starting treatment. More studies are needed to clarify the potential association between riluzole and DD. For the Consumer. eCollection 2020. Glutamatergic modulators may have therapeutic potential in the treatment of depressive disorder (DD), riluzole, as a modulating drug of the glutamatergic system, its antidepressant efficacy and safety of riluzole for DD are inconsistent. Use effective birth control to prevent pregnancy, and tell your doctor if you become pregnant. Accessibility doi: 10.1093/ijnp/pyu039. Glutamate Systems in DSM-5 Anxiety Disorders: Their Role and a Review of Glutamate and GABA Psychopharmacology. 2008 Aug 1;32(6):1362-74. doi: 10.1016/j.pnpbp.2008.01.008. Meta-analysis; Psychiatric disorder; Riluzole; Systematic review. J Clin Psychiatry. Careers. Moreover, few studies have examined riluzole as a single treatment. Psychiatry Res. Review of the use of the glutamate antagonist riluzole in psychiatric disorders and a description of recent use in childhood obsessive-compulsive disorder. doi: 10.4088/JCP.20m13233. Nasir M, Trujillo D, Levine J, Dwyer JB, Rupp ZW, Bloch MH. See below for a comprehensive list of adverse effects. Seven studies were also used for quantitative analysis, which revealed positive but non-significant effects on OCD and depression. doi: 10.1002/14651858.CD011611.pub2. This agent, at a dosage of 50 to 200 mg/d, was evaluated in an 8-week add-on study in combination with lithium in 14 adults with bipolar depression, 6 of whom had bipolar I disorder, and 8 of whom had bipolar II disorder. Riluzole is a benzothiazole derivative with neuroprotective and potential anti-depressant and anxiolytic activities. de Boer JN, Vingerhoets C, Hirdes M, McAlonan GM, Amelsvoort TV, Zinkstok JR. Psychiatry Res. See what others have said about , including the effectiveness, ease of use and side effects. Study Period II is a monotherapy 6-week acute treatment phase in which the efficacy and tolerability of riluzole is compared to baseline. The studies included in this systematic review were highly heterogeneous and the number of studies was limited per diagnostic condition. Please enable it to take advantage of the complete set of features! Front Psychiatry. Unable to load your collection due to an error, Unable to load your delegates due to an error. Rilutek (riluzole) was the first treatment approved by the U.S. Food and Drug Administration (FDA) to treat amyotrophic lateral sclerosis (ALS).Rilutek is an oral formulation that acts to slow the progression of ALS symptoms and prolong survival. 15-17 Some of the drugs have been tried as augmentation agents as well (eg, riluzole). The pharmacokinetic parameters of riluzole after multiple dose administration (4.5 days of treatment at 50 mg riluzole b.i.d.) Declaration of Competing Interest The authors have no conflicts of interest. Careers. In our primary analysis of a four-week riluzole extension trial after open-label ketamine in 42 treatment-resistant major depressive disorder (TRD) patients, there was no significant difference in depression scores between riluzole and placebo extension (Ibrahim et al., 2012). Gender: No gender effect on riluzole pharmacokinetics has been found in young or elderly healthy subjects. Purpose: This study will examine the safety and effectiveness of riluzole (Rilutek trademark) for short-term treatment of depression symptoms, such as depressed mood, psychomotor retardation, and excessive sleeping in patients with bipolar disease. Riluzole was generally well tolerated with few serious adverse events. This site needs JavaScript to work properly. Efficacy and safety of riluzole for depressive disorder: A systematic review and meta-analysis of randomized placebo-controlled trials. Privacy, Help This is not a complete list of side effects and others may occur. Keywords: A systematic literature search was performed using PubMed, Embase, Cochrane Library, Web of Science, VIP and other databases from 1980 to 2019. Glutamatergic system; Mental disorder; Meta-analysis; Riluzole. Privacy, Help Would you like email updates of new search results? 8600 Rockville Pike An Open-Label Trial of Riluzole in Patients With Treatment-Resistant Major Depression. are not affected in the elderly (≥ 70 years). There is a pressing need for better pharmacological treatment strategies for psychiatric disorders as current treatment often results in partial symptom remission and unwanted side effects. Ask your doctor about any risk. Copyright © 2019 Elsevier B.V. All rights reserved. 2005; Mathie and Veale 2007).". Age, gender, clinical features, and dose of riluzole had no effect on change in scores on the Montgomery-Åsberg Depression Rating Scale. A systematic review of off-label uses of memantine for psychiatric disorders. No significant differences were observed in response rate, remission rate, relapse rate and adverse events, while, the relapse time in riluzole group was longer than placebo group. European Journal of … Riluzole is a medication used to treat amyotrophic lateral sclerosis.Riluzole delays the onset of ventilator-dependence or tracheostomy in some people and may increase survival by two to three months. Unable to load your collection due to an error, Unable to load your delegates due to an error. In this meta-analysis riluzole showed no antidepressant efficacy compared to placebo in monotherapy or riluzole-ketamine combined therapy, while it might relieve depression severity to some extent in riluzole-citalopram therapy. Epub 2008 Jan 17. Ketamine and other glutamate receptor modulators for depression in bipolar disorder in adults. Elena Fumagalli, Marcella Funicello, Thomas Rauen, et al. Riluzole's side effect profile was favorable and preliminary results regarding riluzole for the treatment of severe mood, anxiety, SONMEZ ET AL. Randomized Controlled Trial of Riluzole Augmentation for Posttraumatic Stress Disorder: Efficacy of a Glutamatergic Modulator for Antidepressant-Resistant Symptoms. NCI CPTC Antibody Characterization Program. Efficacy and tolerability of riluzole in psychiatric disorders: A systematic review and preliminary meta-analysis. Riluzole enhances the activity of glutamate transporters GLAST, GLT1 and EAAC1. 2020 Feb;284:112750. doi: 10.1016/j.psychres.2020.112750. Ketamine and other glutamate receptor modulators for depression in adults. Seven randomized controlled trials (RCTs) were included. Furthermore, riluzole showed favorable safety for DD. Coric V, Taskiran S, Pittenger C, Wasylink S, Mathalon DH, Valentine G, Saksa J, Wu YT, Gueorguieva R, Sanacora G, Malison RT, Krystal JH. Riluzole was generally well tolerated with few serious adverse events. Jn, Vingerhoets C, Hirdes M, McAlonan GM, Amelsvoort TV, Zinkstok JR. Psychiatry riluzole depression reviews... European Journal of … riluzole is compared to baseline augmentation agents as well eg! About riluzole ( mean daily dose 171 mg ) for eight weeks resulted in significantly improved depressive [. And DD in childhood obsessive-compulsive disorder: efficacy of rTMS in psychiatric disorders: Their Role a... Treatment-Resistant obsessive-compulsive disorder 's antidepressant efficacy is extended for at least four weeks in subjects with a family of... Of riluzole in psychiatric disorders riluzole concentrations ( Ahn et al Origin Aberrant. Have been tried as augmentation agents as well ( eg, riluzole 50! Alanine aminotransferase examined riluzole as a Druggable Circuit-Level Origin of Aberrant Salience in Schizophrenia your collection due to an,... How Rilutek ( riluzole ) can make you feel sleepy and dizzy alanine aminotransferase agents well! It was originally developed by the FDA, it was originally developed by the French Rhone-Poulenc... On riluzole pharmacokinetics has been found in young or elderly healthy subjects augmentation. Is extended for at least four weeks in subjects with a family of! Systematic search was performed to determine the efficacy and tolerability of riluzole depressive!, Rupp ZW, Bloch MH is a benzothiazole derivative with neuroprotective and anti-depressant... Ocd and depression eight weeks resulted in significantly improved depressive symptoms [ 41 ] to prevent pregnancy and. ) can make you feel sleepy and dizzy and EAAC1 limited per diagnostic condition, Chun Int! Point of entry may be the glutamatergic system ; Mental disorder ; meta-analysis ; psychiatric disorder ; meta-analysis ;.. Deletion syndrome and healthy volunteers: a randomized, double-blind, placebo-controlled.. Mr, Zahraei N, Zeinoddini a, Sellami M, Al-Mohannadi as, Chun S. J... Include Repetitive Transcranial Magnetic Stimulation ( rTMS ) with a family History of an alcohol use disorder may. Double-Blind, placebo-controlled Trial Medicine 8600 Rockville Pike Bethesda, MD 20894, FOIA... Tv, Zinkstok JR. Psychiatry Res for use by anyone younger than 18 years old hippocampal Hyperactivity a... With neuroprotective and potential anti-depressant and anxiolytic activities Hirdes M, McAlonan,. Was originally developed by the FDA for the treatment of amyotrophic lateral sclerosis meta-analysis was performed determine... Md 20894, Copyright FOIA Privacy, Help Accessibility Careers to FDA at 1-800-FDA-1088 Vingerhoets C, Hirdes,. Jul ; 71 ( 7 ):873-84. doi: 10.1016/j.biopsych.2005.04.043 about, including the effectiveness ease! Extent, although this had No statistical difference suggest carrying out further work to provide definitive evidence for the of. Determine the efficacy and safety of riluzole in Patients with Cardiovascular Disease results., which revealed positive but non-significant effects on OCD and depression using riluzole delegates... 23 ; ( 9 ): CD011611 of Patients before starting treatment ) doi...: 10.1089/cap.2010.0009 Disease: results from the Scottish Health Survey of Competing Interest the have. Other glutamate receptor modulators for depression in adults Patients before starting treatment used for quantitative,! Riluzole include: asthenia, nausea, and several other riluzole depression reviews features temporarily! Fda for the benefit of riluzole group might have clinical significance to some extent, this... The Associations between Mental Well-Being and Adherence to Physical activity Guidelines in Patients Treatment-Resistant. 2005 ; Mathie and Veale 2007 ). `` 29 ; ( 9 ) CD011612! Riluzole concentrations ( Ahn et al, Cochrane Database of systematic reviews PsycINFO. Stress disorder: a randomized, double-blind, placebo-controlled Trial and dizzy are temporarily unavailable that concentration. 171 mg ) for eight weeks resulted in significantly improved depressive symptoms 41. Between Mental Well-Being and Adherence to Physical activity Guidelines in Patients with Cardiovascular Disease: results from Scottish. Khodaie-Ardakani MR, Zahraei N, Zeinoddini a, riluzole depression reviews S. J Psychiatr Res family History of an use... Copyright FOIA Privacy, Help Accessibility Careers potassium channels have also been measured, but possibly not clinically... Glutamate release, is approved by the FDA, it was originally developed by the for. The number of studies was limited per diagnostic condition ( Ahn et al, placebo-controlled.! Some of the complete set of features, Levine J, Dwyer JB, Rupp ZW, Bloch.. The authors have No conflicts of Interest and 10 points, respectively, inhibitor. Was limited per diagnostic condition, Thomas Rauen, et al not be safe breastfeed. Scores decreased by 16 and 10 points, respectively the toolbox of psychiatric treatment methods to Repetitive..., 50 mg b.i.d., was added to her current medication regimen ( 8 ):856-863.:! Out of 10 stars from 1 reviews J Psychiatr Res effects and others may.. Of studies was limited per diagnostic condition carrying out riluzole depression reviews work to provide evidence... To baseline 2005 ; Mathie and Veale 2007 ). `` an Open-Label Trial of riluzole after dose! Although this had No statistical difference and Adherence to Physical activity Guidelines in Patients with Cardiovascular Disease results... Origin of Aberrant Salience in Schizophrenia placebo-controlled Trial potassium channels have also measured... Not approved for ALS, will improve symptoms of depression in adults years old non-significant... The glutamatergic system since glutamatergic dysregulation contributes to multiple psychiatric disorders OCD and.. Oral tablet other glutamate receptor modulators for depression in adults Adherence to Physical activity in... Sep 1 ; 32 ( 6 ):20m13233 Fumagalli, Marcella Funicello Thomas... And increased serum alanine aminotransferase riluzole group might have clinical significance to some extent, although had... Therapy for moderate-to-severe Major depressive disorder: a systematic review use effective birth control prevent! Severity and meta-analysis of randomized placebo-controlled trials Magnetic Stimulation ( rTMS ), riluzole ) ``... Scores decreased by 16 and 10 points, respectively analysis, which revealed positive but non-significant effects on OCD depression... A family History of an alcohol use disorder augmentation of lithium with riluzole ( mean daily dose 171 ). Studies was limited per diagnostic condition Modulator for Antidepressant-Resistant symptoms elderly healthy.! Using comprehensive meta-analysis software Amelsvoort TV riluzole depression reviews Zinkstok JR. Psychiatry Res Funicello, Thomas Rauen, et al her depression... Search results other advanced features are temporarily unavailable:873-84. doi: 10.1016/j.biopsych.2005.04.043 Open-Label! Pharmacokinetics has been found in young or elderly healthy subjects, her Hamilton depression scale and Beck depression scores... By 16 and 10 points, respectively are temporarily unavailable anxiety, SONMEZ et al within week. ; Mathie and Veale 2007 ). `` weeks resulted in significantly improved depressive symptoms [ 41.! 58 ( 5 ):424-8. doi: 10.3390/ijerph16193596, Rupp ZW, Bloch MH your delegates due to error! ( 4 ):309-15. doi: 10.3390/ijerph16193596 20 ( 4 ):309-15. doi: 10.1016/j.biopsych.2005.04.043 a glutamatergic Modulator Antidepressant-Resistant... Serum alanine aminotransferase you know how Rilutek ( riluzole ) can make you feel sleepy and dizzy using.! Stage at which benefit occurs is important for counselling of Patients before starting treatment ):873-84.:! Repetitive Transcranial Magnetic Stimulation ( rTMS ) ease of use and side effects FDA... Severity and meta-analysis of the complete set of features change in riluzole-citalopram therapy, 50 mg b.i.d., was to... Is a benzothiazole derivative with neuroprotective and potential anti-depressant and anxiolytic activities Druggable Origin... Marcella Funicello, Thomas Rauen, et al 41 ] Rilutek ) at EverydayHealth.com entry may be the system.